Érick Gamelin
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 62
- Cancer Treatment and Pharmacology 43
- Cancer-related Molecular Pathways 9
- Cancer Immunotherapy and Biomarkers 9
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Dermatology top 1%
- Pharmacology top 1%
-
- Gastric Cancer Management and Outcomes 14
-
- Cancer therapeutics and mechanisms 14
-
- Microtubule and mitosis dynamics 11
- Co-authors
- M. Boisdron‐CelleAlain MorelLaurence GamelinR. DelvaS. BrienzaOlivier CoqueretNorbert IfrahArnaud Vigneron
- Cited by
- OncologyHepatologyDermatology
- Journals
- Journal of Clinical Oncology (23 papers)Cancer Research (8 papers)European Journal of Cancer (7 papers)
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Érick Gamelin
137 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 121
- Oncology 4.2k
- Hepatology 512
- Dermatology 511
- Pharmacology 352
- Pathology and Forensic Medicine 676
Countries citing papers authored by Érick Gamelin
This map shows the geographic impact of Érick Gamelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Érick Gamelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Érick Gamelin more than expected).
Fields of papers citing papers by Érick Gamelin
This network shows the impact of papers produced by Érick Gamelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Érick Gamelin. The network helps show where Érick Gamelin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Érick Gamelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 12 | |
| 2 | 2021 | 15 | |
| 3 | 2012 | 67 | |
| 4 | 2011 | 47 | |
| 5 | 2009 | 6 | |
| 6 | 2008 | 51 | |
| 7 | 2008 | 52 | |
| 8 | 2007 | 17 | |
| 9 | Neurotoxicité de l’oxaliplatine | 2006 | 1 |
| 10 | 2006 | 173 | |
| 11 | 2006 | 39 | |
| 12 | 2003 | 17 | |
| 13 | 2003 | 4 | |
| 14 | 2003 | 3 | |
| 15 | 2002 | 18 | |
| 16 | Carcinoma of unknown primary site: 311 cases | 2001 | 3 |
| 17 | Pharmacocinétique clinique comparative des dérivés du platine | 2001 | 1 |
| 18 | 1999 | 45 | |
| 19 | 1999 | 17 | |
| 20 | 1996 | 180 |
About Érick Gamelin
Érick Gamelin is a scholar working on Oncology, Hepatology and Cancer Research, having authored 138 papers that have together received 6.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (62 papers), Cancer Treatment and Pharmacology (43 papers), Gastric Cancer Management and Outcomes (14 papers), Cancer therapeutics and mechanisms (14 papers), Microtubule and mitosis dynamics (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cancer-related Molecular Pathways (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (4.2k citations), Hepatology (512 citations) and Dermatology (511 citations). Érick Gamelin has collaborated with scholars based in France, United States and Australia. Frequent co-authors include M. Boisdron‐Celle, Alain Morel, Laurence Gamelin, R. Delva, S. Brienza, Olivier Coqueret, Norbert Ifrah, Arnaud Vigneron, Stefan Quasthoff and Laura Bossi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, European Journal of Cancer, Annals of Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.